Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-15

Clinical Trial Update: Effect of Dolutegravir Intensification on HIV-1 Reservoirs [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of dolutegravir intensification on HIV-1 reservoirs in adults with HIV-1 infection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)

Snippet

Sponsor: University of Liege | Conditions: HIV-1-infection | Phase 2 | Status: COMPLETED